Crispr Therapeutics Ag (CRSP) — SC 13G/A Filings
All SC 13G/A filings from Crispr Therapeutics Ag. Browse 7 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (7)
- SC 13G/A Filing — Dec 10, 2024
- SC 13G/A Filing — Apr 10, 2024
-
Nikko Asset Management Exits CRISPR Therapeutics Stake
— Feb 12, 2024 Risk: medium
Nikko Asset Management Americas, Inc. filed an amended SC 13G/A on February 12, 2024, indicating a significant change in their beneficial ownership of CRISPR Th -
Capital International Investors Trims CRISPR Therapeutics Stake to 7.6%
— Feb 9, 2024 Risk: low
Capital International Investors, a major institutional investor, filed an amended SC 13G/A on February 9, 2024, disclosing their ownership in CRISPR Therapeutic -
Sumitomo Mitsui Trust Amends CRISPR Therapeutics Stake
— Feb 5, 2024
Sumitomo Mitsui Trust Holdings, Inc. (SMTH) filed an amended Schedule 13G/A on February 5, 2024, indicating their beneficial ownership in CRISPR Therapeutics AG -
ARK Investment Management Holds 9.9% Stake in CRISPR Therapeutics
— Jan 29, 2024
ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership in CRISPR Therapeutics AG (CRSP) as o -
ARK Investment Management Discloses 9.9% Stake in CRISPR Therapeutics
— Jan 10, 2024
ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 10, 2024, disclosing its ownership in CRISPR Therapeutics AG as of Decem
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX